Jin F, Qiu Y, Wu Z, Wang YH, et al. Immunogenicity and safety of a SARS-CoV-2 mRNA vaccine (SYS6006) in healthy Chinese participants: A randomized, observer-blinded, placebo-controlled phase 2 clinical trial. Vaccine 2024 Feb 15:S0264-410X(24)00124-5. doi: 10.1016/j.vaccine.2024.
PMID: 38365485